|
|
Volumn 316, Issue 7132, 1998, Pages 648-
|
|
Marketing of antipsychotic drugs attacked.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BENZODIAZEPINE DERIVATIVE;
DRUG DERIVATIVE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PIRENZEPINE;
RISPERIDONE;
ADVERTIZING;
ARTICLE;
DRUG INDUSTRY;
ELI LILLY;
GOVERNMENT;
GOVERNMENT REGULATION;
HEALTH CARE AND PUBLIC HEALTH;
HUMAN;
MENTAL HEALTH THERAPIES;
MENTAL PATIENT;
PROFESSIONAL PATIENT RELATIONSHIP;
SCHIZOPHRENIA;
ELI LILLY;
HEALTH CARE AND PUBLIC HEALTH;
MENTAL HEALTH THERAPIES;
PROFESSIONAL PATIENT RELATIONSHIP;
ADVERTISING;
ANTIPSYCHOTIC AGENTS;
BENZODIAZEPINES;
DRUG INDUSTRY;
FEDERAL GOVERNMENT;
GOVERNMENT REGULATION;
HUMANS;
MENTALLY ILL PERSONS;
PIRENZEPINE;
RISPERIDONE;
SCHIZOPHRENIA;
|
|
EID: 0032573950
PISSN: 09598138
EISSN: None
Source Type: Journal
DOI: 10.1136/bmj.316.7132.645g Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
